drugset / Trial / NCT03747081
Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
RandomizedParallel-groupOpen-labelTreatment
Summary
With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease, specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such as Warfarin, require laboratory monitoring and exact administration starting and maintenance dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2020-01-01
- Completion
- 2020-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | 20 mg | — |
| Comparator | Warfarin | Small molecule | — | — |